Money & Banking

Arogya Sanjivani will cover Covid-19 hospitalisation charges, says IRDAI

Surabhi Mumbai | Updated on April 02, 2020 Published on April 02, 2020

Clears 29 insurers to market standard health insurance product

The Insurance Regulatory and Development Authority of India (IRDAI) has said Arogya Sanjivani, a newly launched standard health insurance product, will cover hospitalisation charges to treat coronavirus infection.

The regulator has also approved 29 general and health insurance companies to market Arogya Sanjivani. These include Raheja QBE General Insurance, New India Assurance, Bajaj Allianz General Insurance and United India Assurance, among others.

“…the product Arogya Sanjeevani, offered by the above general and health insurers, also covers the hospitalisation treatment costs of Covid-19,” it said.

Expedited settlement

In a recent statement, the IRDAI also said that indemnity-based health insurance products that cover the treatment costs of hospitalisation offered by all general and health insurance companies shall also cover the costs of hospitalisation treatment on account of Covid-19. “All insurers have been advised by the Authority...to expedite the settlement of Covid-19 related claims,” it said, adding that they have also been advised to display FAQs on Covid-19 claims on their respective websites.

The insurance regulator had earlier this year cleared Arogya Sanjivani, issuing final guidelines on the health policy. The product, rolled out on April 1, provides basic health cover of ₹1-5 lakh.

IRDAI has also been closely monitoring how insurance companies are handling the coronavirus outbreak and any claims arising out of it. It has issued a number of circulars and advisories directing insurers to expedite all claims arising out of the infection

Published on April 02, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.